Access, assistance, affordability, and more
The following resources can help you initiate and maintain INVEGA TRINZA® (paliperidone palmitate) for clinically appropriate patients. Click the links below to learn more about the information, assistance, and savings offered through these programs.
Eligible commercial patients pay no more than $10 per Rx purchased at a pharmacy.
Program exhausts after 4 doses of INVEGA TRINZA®, or $6000, whichever comes first.
Click here for full program and eligibility requirements.
This program is not available to individuals enrolled in federal or state subsidized health care programs that cover prescription drugs, including Medicare, such as Medicare Part D prescription drug benefit, Medicaid, TRICARE, or any other federal or state health care plan, including pharmaceutical assistance programs.
Full subsidy LIS* patients may be eligible to pay $3.70 to $8.25 for branded drugs.
It is important to make sure your patients and their caregivers understand the benefits and risks of taking INVEGA TRINZA® (paliperidone palmitate). Download the easy-to-understand brochure below to help get them started.
You can also direct them to the consumer site for more information: invegatrinza.com.
Janssen Scientific Affairs Medical Information Center
If you have an immediate question about one of the products from Janssen Pharmaceuticals, Inc., or if you would like to report a possible adverse reaction or product quality complaint, call Janssen Scientific Affairs Medical Information Center at 1-800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET and Saturday/Sunday from 9:00 AM to 5:00 PM ET.
Access the Medical Information Center
Access the Medical Information Center to get product information: janssenmd.com.